Overview
- 180 Life Sciences issued $156 million in convertible notes due 2028 to fund further ether acquisitions.
- The company’s treasury now includes 82,186 ETH valued at about $349 million alongside $238 million in cash.
- Executive Chairman McAndrew Rudisill said more than $350 million of capital has been deployed since the initial $425 million PIPE.
- The firm plans to rebrand as ETHZilla and engage Electric Capital to run on-chain yield strategies designed to outperform traditional staking.
- Shares surged over 230% intraday after the note closing and an SEC filing revealed a 7.5% stake by Peter Thiel, while observers caution that high leverage and concentrated ETH holdings carry systemic risks.